Skip to main content
TipRanks
Go Ultimate75% OFF

Houssem Ben Tahar Insider Profile

4 Followers

Houssem Ben Tahar, Vice-President at Diagnos, holds 292.50K shares in Diagnos (Ticker: TSE:ADK). Most recently, Houssem Ben Tahar Bought 150,000 shares of Diagnos on Feb 12, 2013 for an estimated value of C$15.00K.

Houssem Ben Tahar's Trading History

ADK
Diagnos
Feb 12, 2013Vice-PresidentInformative Buy15.00KC$92.14K
TSE:ADK
Insider Shares: 292.50K (46.56%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 12, 2013Informative BuyC$15.00K150,000C$0.10-16.00%―
Nov 28, 2011Uninformative SellC$13.00K50,000C$0.26――
Jun 15, 2011Uninformative SellC$6.67K33,334C$0.20――
Nov 24, 2010Uninformative SellC$3.83K16,668C$0.23――
Mar 03, 2010Informative SellC$5.81K14,000C$0.42+23.10%―

You May Also Like

Houssem Ben Tahar insider profile FAQ

What is the percentage of profitable transactions made by Houssem Ben Tahar?
The percentage of profitable transactions made by Houssem Ben Tahar is 50%.
What is the average return per transaction made by Houssem Ben Tahar?
The average return per transaction made by Houssem Ben Tahar is 3.50%.
What stocks does Houssem Ben Tahar hold?
Houssem Ben Tahar holds: TSE:ADK stocks.
What was Houssem Ben Tahar’s latest transaction?
Houssem Ben Tahar’s latest transaction was an Informative Buy of C$15.00K.
What was Houssem Ben Tahar's most profitable transaction?
Houssem Ben Tahar’s most profitable transaction was an Informative Sell of TSE:ADK stock on March 3, 2010. The return on the trade was 23.10%.
What is Houssem Ben Tahar's role in Diagnos?
Houssem Ben Tahar's role in Diagnos is Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.